HOME PRACTICE AREAS ABOUT US CONTACT US STATE RESOURCES CASE REVIEW
  VIDEO LIBRARY   TODAY'S LEGAL HEADLINES   LEGAL DICTIONARY   testimonials   STATUTE OF LIMITATIONS  
 
Areas of Practice
Contact Us
 

Rezulin

On March 21, 2000 the head of the FDA's Center for Drug Evaluation and Research (CDER) stated that "continued use of Rezulin posed an unacceptable risk to diabetes patients." This was not first time the drug's dangers were called into question. In 1996, during the FDA approval stage, the lead medical officer cited Rezulin as potentially harming to the liver and the heart. The drug, however, was approved in January 1997. By fall of 1997, dozens of patients on Rezulin were hospitalized and cases of hepatocellular cancer, ...MORE >>


Related Information
Links and Resources
View Complete List >>

Featured Articles on Rezulin
Browse Books About Drug Litigation


1.The Drug Lords : America's...

2.Deadly Drug Interactions : The People's...

3.The Pdr Family Guide to Prescription...

4.The Essential Guide to Prescription...

5.2001 Mosby's GenRx: A Comprehensive...

6.The American Pharmaceutical...





The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use.

 
Copyright 2008 | Home | Contact 404-526-8866